ID: ALA4560021

Max Phase: Preclinical

Molecular Formula: C25H23FN4O2

Molecular Weight: 430.48

Molecule Type: Unknown

Representations

Canonical SMILES:  C[C@@H]1[C@@H](O)[C@@H](O)[C@@]2(n3cc(-c4ccc(F)cc4)c4c(Nc5ccccc5)ncnc43)C[C@@H]12

Standard InChI:  InChI=1S/C25H23FN4O2/c1-14-19-11-25(19,22(32)21(14)31)30-12-18(15-7-9-16(26)10-8-15)20-23(27-13-28-24(20)30)29-17-5-3-2-4-6-17/h2-10,12-14,19,21-22,31-32H,11H2,1H3,(H,27,28,29)/t14-,19-,21+,22+,25+/m0/s1

Standard InChI Key:  LQHXSAARKQNOMY-NDQDJNLBSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 430.48

Molecular Weight (Monoisotopic): 430.1805

AlogP: 4.07

#Rotatable Bonds: 4

Polar Surface Area: 83.20

Molecular Species: NEUTRAL

HBA: 6

HBD: 3

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 13.23

CX Basic pKa: 4.90

CX LogP: 3.95

CX LogD: 3.95

Aromatic Rings: 4

Heavy Atoms: 32

QED Weighted: 0.45

Np Likeness Score: -0.16

References

1. Toti KS, Osborne D, Ciancetta A, Boison D, Jacobson KA..  (2016)  South (S)- and North (N)-Methanocarba-7-Deazaadenosine Analogues as Inhibitors of Human Adenosine Kinase.,  59  (14): [PMID:27410258] [10.1021/acs.jmedchem.6b00689]

Source

Source(1):

• Scientific Literature